OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Christopher A. Klebanoff, Smita S. Chandran, Brian M. Baker, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 996-1017
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Bispecific and multispecific antibodies in oncology: opportunities and challenges
Maria-Elisabeth Goebeler, Gernot Stuhler, Ralf C. Bargou
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 7, pp. 539-560
Closed Access | Times Cited: 29

HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy
Qinqin Jiang, David A. Braun, Karl R. Clauser, et al.
Cell (2025)
Open Access | Times Cited: 2

Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening
Ziva Moravec, Yue Zhao, Rhianne Voogd, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 8

CryoEM structure of an MHC-I/TAPBPR peptide-bound intermediate reveals the mechanism of antigen proofreading
Yi Sun, Ruth A. Pumroy, Leena Mallik, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 2
Open Access | Times Cited: 1

Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies
John B.A.G. Haanen, Christy Los, Giao Q. Phan, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 5

Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?
Alexander F. Wang, Brian Hsueh, Bryan D. Choi, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 5, pp. 628-643
Closed Access | Times Cited: 4

Modifications to rhesus macaque TCR constant regions improve TCR cell surface expression
Lori V. Coren, Matthew T. Trivett, Jorden L. Welker, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314751-e0314751
Open Access

The Evolving T Cell Receptor Recognition Code: The Rules Are More Like Guidelines
George I. Gray, P. Chukwunalu Chukwuma, Bassant Eldaly, et al.
Immunological Reviews (2025) Vol. 329, Iss. 1
Closed Access

Current developments in T-cell receptor therapy for Acute Myeloid Leukaemia
Steven D. Gore, Emily Blyth, Marie Bleakley, et al.
Blood Advances (2025)
Open Access

Fast and accurate modeling of TCR-peptide-MHC complexes using tFold-TCR
Fandi Wu, Yu Zhao, Yang Xiao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognition
Xiaojian Han, Xiaxia Han, Yanan Hao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci
Christopher Chang, Vivasvan S. Vykunta, J H Lee, et al.
Nature Biotechnology (2025)
Open Access

Tuning TCR complex recruitment to the T cell antigen coupler (TAC) enhances TAC-T cell function
Trevor M. Morey, Tania Benatar, Stacey X. Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H
Volker Lennerz, Christoph Doppler, Martina Fatho, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Hexokinase2-engineered T cells display increased anti-tumor function
Raphaëlle Toledano Zur, Shiran Didi Zurinam, Maria Radman, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Adoptive immune cell therapy for colorectal cancer
Chenxiao Liu, Nan Liu, Tongcun Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
Martin Wermke, Dejka M Araurjo, Manik Chatterjee, et al.
Nature Medicine (2025)
Open Access

The resting and ligand-bound states of the membrane-embedded human T-cell receptor– CD3 complex
Ryan Q. Notti, Fei Yi, Søren Heissel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 11

Enhanced T cell receptor specificity through framework engineering
Aaron M. Rosenberg, Cory M. Ayres, Angélica V. Medina‐Cucurella, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Influence of Microbiota on Tumor Immunotherapy
Xin Yu, Wenge Li, Zhi Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2264-2294
Open Access | Times Cited: 4

Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS mutations
Gerald P. Linette, Adham S. Bear, Beatriz M. Carreno
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2017-2024
Open Access | Times Cited: 3

Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors
Adham S. Bear, Rebecca B. Nadler, Mark H. O’Hara, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 21
Open Access | Times Cited: 3

TCR3d 2.0: expanding the T cell receptor structure database with new structures, tools and interactions
Valerie C. L. Lin, Melyssa Cheung, Ragul Gowthaman, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D604-D608
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top